Background & evidence — clinical AI for low-resource health settings

Research on infrastructure, health-data governance and open models informs OpenClinAI's clinical AI experiments. Sources include WHO guidance, peer-reviewed literature and recent preprints. Confidence notes distinguish reported findings from qualified estimates; some guidance and paywalled studies are represented by official summaries or abstracts rather than full texts.

1. WHO SMART Guidelines — computable, guideline-concordant care

• SMART = Standards-based, Machine-readable, Adaptive, Requirements-based, Testable — WHO's approach to getting its recommendations into countries' digital systems faithfully and fast. (WHO, "From paper to digital pathway," 18 Feb 2021 — who.int/news; confirmed across 3 sources incl. JMIR 2025. high)
• They are "a comprehensive set of reusable digital health components … that transform the guideline adaptation and implementation process to preserve fidelity and accelerate uptake." (WHO Digital Health & Innovation — who.int/teams/digital-health-and-innovation/smart-guidelines. high)
• Organized into five knowledge layers (L1–L5) — "a systematic, transparent and testable structure": L1 Narrative (human-readable recommendations) → L2 Operational (software-neutral requirements, delivered as Digital Adaptation Kits) → L3 Machine-readable (structured specs with coding/terminology/interoperability standards) → L4 Executable (software running static algorithms) → L5 Dynamic (algorithms optimized with analytics). (WHO smart.who.int DAK pages; L1–L4 high, L5 one-line definition medium — WHO confirms the name "Dynamic" but L5 content is largely "not yet available".)
• Motivation (peer-reviewed): converting narrative guidelines to digital systems has been "laborious, prone to error, and lacks accompanying technical documentation appropriate for digital use." (Muliokela et al., JMIR Medical Informatics, 7 Feb 2025 — medinform.jmir.org/2025/1/e58858. high) Foundational paper: Mehl et al., "WHO SMART guidelines…," Lancet Digital Health, 2021 (PMID 33610488 — thesis confirmed, full text paywalled).
• Project tie-in: the harness asks for the same property SMART Guidelines demand of software — answers that are standards-based, verifiable, and traceable, not opaque.

2. WHO ethics & governance of AI / LMMs in health

• WHO's first global guidance, "Ethics and governance of artificial intelligence for health" (28 Jun 2021, ISBN 9789240029200), sets six principles: human autonomy; well-being/safety/public interest; transparency & explainability; responsibility & accountability; inclusiveness & equity; responsive & sustainable AI. (who.int/news 28-06-2021. high)
• Equity warning: AI "systems trained primarily on data collected from individuals in high-income countries may not perform well for individuals in low- and middle-income settings." (WHO, 28 Jun 2021. high)
• Second, dedicated guidance, "…Guidance on large multi-modal models (LMMs)" (18 Jan 2024, ISBN 9789240084759), 40+ recommendations. (who.int/news 18-01-2024. high)
• Hallucination/harm: LMMs carry "documented risks of producing false, inaccurate, biased, or incomplete statements, which could harm people using such information in making health decisions." (WHO, 18 Jan 2024. high)
• Automation bias: LMMs "can also encourage 'automation bias' … whereby errors are overlooked that would otherwise have been identified." (WHO, 18 Jan 2024. high)
• Data risk: data disclosed to LMM developers "can usually not be retrieved as future iterations of the model may be trained on this data." (WHO, 18 Jan 2024. high)
• Safeguards WHO recommends: inclusive design with clinicians/patients from the start; mandatory independent post-release auditing & impact assessment; assigning a regulator to approve health LMMs; models designed "to perform well-defined tasks with the necessary accuracy and reliability." (WHO, 18 Jan 2024. high)

3. Why low-resource settings need a different design

• Electricity: "Close to 1 billion people in low- and lower-middle-income countries are … served by health-care facilities without reliable electricity or with no electricity at all." In sub-Saharan Africa only 40% of facilities have reliable electricity, 15% none. (WHO fact sheet, 31 Aug 2023 — who.int/news-room/fact-sheets/detail/electricity-in-health-care-facilities. high)
• Connectivity: 78% of people in low-income countries are offline (vs 7% in high-income); in rural low-income areas only 1 in 6 (16%) use the internet. (ITU Facts and Figures 2024. high)
• Workforce: WHO projects a shortfall of ~11 million health workers by 2030, mostly in low/lower-middle-income countries. (WHO health-workforce page. high for current figure; the number has moved 10–18M across WHO docs/years — treat as version-dependent.)
• Research/data concentration: >87% of healthcare-LLM research is led by high-income-country institutions; Africa ≈0.31% despite ~20% of world population. (Chen et al., Lancet Regional Health – Western Pacific, Oct 2025 — PMC12556221. high)
• Performance gap: "LLMs make up to three times more errors when retrieving information related to low-income countries"; accuracy can fall "from around 80% in English to just 50% in Thai." (Chen et al., 2025. high for citation; underlying primary numbers medium.)
• Cloud economics: a 70B model needs 8 A100 GPUs (US$300k/yr cloud); serving one per 100k people "could consume up to 15% of national healthcare expenditure"; even a $20/mo fee "exceeds the financial means of nearly half the global population." (Chen et al., 2025. high as reported.)
• Independent confirmation + recommendation: 2026 scoping review (44 studies) — fragile infrastructure a barrier in 77.3%, hardware limits 50%, literacy/staffing gaps 61.4%, fragmented/paper records 81.8%; recommends "offline-capable AI models with local data caching." (Al-Ganad et al., Frontiers in Digital Health, 2026. high)
• Project tie-in: unreliable infrastructure motivates experiments with locally hosted models and application-supplied clinical context. Disconnected operation depends on the complete service configuration and available hardware.

4. Data privacy, sovereignty & local ownership

• Sovereignty: at WHO's May 2026 digital-health/AI debate, LMICs warned AI "risks accelerating data extraction"; Cameroon (African Region) feared corporations would "harvest data from the Global South to train AI models"; Barbados argued health data should be "a national asset under local control." (Health Policy Watch, 2 May 2026. high)

• Governance principle: the Health Data Governance Principles support federated approaches that keep data near its point of generation, informing the case for local processing. (Transform Health, 2022. Paraphrase of the published principles.)

• Cloud-LLM privacy risk: a review of 464 healthcare-LLM studies found six privacy risks from external/cloud LLMs and that 38.4% reported no PHI-protection measures; its top recommendation: "Priority should be given to deploying the LLM locally." (Zhong et al., JMIR, 21 Nov 2025 — jmir.org/2025/1/e76571. high)

• Data colonialism: research on decolonizing global health examines extractive practices that move data away from the communities that generate it. (Scoping review, 2025. Concept summarized, not a verbatim definition.)

• Project tie-in: local processing can reduce disclosure risk. Verify configured providers, evaluation services and evidence redaction for each deployment; this is not a blanket privacy guarantee.

5. Open-weight models & right-sizing per task

• Small can run offline: a 3.8B open model (Phi-3-mini) runs fully offline on an iPhone in ~1.8 GB at >12 tok/s, at roughly GPT-3.5 quality. (Microsoft Research, Phi-3 Technical Report, Apr 2024 — arxiv.org/abs/2404.14219. high)
• Open is closing the gap: on 1,933 real radiology cases, closed GPT-4o scored 79.6% and open Llama-3-70B 73.2%; authors: "open-source LLMs are quickly closing the gap to proprietary LLMs." (Kim et al., npj Digital Medicine, 12 Feb 2025 — PMC11814077. high)
• Medical open models: MedGemma (open, Gemma-3-based, 4B/27B) scores 64.4% (4B) / 87.7% (27B w/ test-time scaling) on MedQA vs 50.7%/74.9% base; authors recommend it when a use case needs "ability to run locally or offline." (Sellergren et al., Google, Jul 2025 — arxiv.org/abs/2507.05201. high; the 87.7% includes test-time scaling.)
• Right-sizing / routing: matching model size to task difficulty (small for easy, escalate to large only for hard) yields large savings (e.g. a router hitting 97% of GPT-4 quality at ~24% cost). (Moslem & Kelleher survey, ADAPT/TCD, Apr 2026 — arxiv.org/abs/2603.04445. Direction high; exact percentages medium, setup-dependent.)
• Capable size range on modest hardware: Llama 3.2 1B, Qwen2.5 1.5B, Gemma 2 2B/9B, Phi-3-mini 3.8B/Phi-4 14B, Mistral 7B — 1–9B built for on-device. (model cards; anchored by Phi-3. high.)
• Safety limit — small models can't self-verify: AI self-verification wrongly accepted incorrect medical answers >60% of the time, and smaller models were no better — "cannot serve as a universal safety layer." (Jin et al., "Verification Mirage," UBC/Vector, May 2026 — arxiv.org/abs/2605.10850. medium, recent preprint, consistent w/ peer-reviewed LLM-as-judge literature.) This motivates independent evidence-based evaluation and human review; a larger model's judgment also needs validation for the task.
• Project tie-in: applications can use configured open models, while harness experiments use separately selected evaluation methods and reviewers. Model evaluation may use local or remote services; provider configuration determines connectivity and disclosure requirements.

Study limitations: the self-verification finding is reported in a recent preprint, not established deployment performance. MedGemma's 27B headline result includes test-time scaling.

How the external evidence maps to the project (the through-line)

The research supports local processing, context appropriate to the deployment, and independent evaluation against recorded evidence as priorities for clinical AI experiments.